Skip to main content
Premium Trial:

Request an Annual Quote

Cigna Using Telegenomics Services From Genome Medical

NEW YORK (GenomeWeb) -- Telegenomics technology company Genome Medical has begun providing genetic counseling services for insurer Cigna as of Oct. 1.

Genome Medical employs a team of more than 40 genetics experts and providers who conduct telehealth consultations in the areas of primary care, cancer, cardiovascular conditions, reproductive health, pediatrics, and pharmacogenetics. These experts can evaluate and make care decision for patients, and facilitate peer-to-peer consultations for providers.

"Adding Genome Medical to our genetic counseling program expands access for our customers and contracted care providers to a highly-specialized nationwide practice of credentialed, in-network and certified genetic counselors," Jeffrey Hankoff, Cigna's medical director, said in a statement.

Genome Medical CEO Lisa Alderson lauded Cigna for being innovative in its decision to incorporate the company’s telegenomics services. "Cigna's selection of Genome Medical demonstrates the importance of making genetic expertise and genomic services an integrated part of how patients receive care, and providers deliver it," Alderson said.

Headquartered in South San Francisco, Genome Medical has financial backing from Canaan Partners, GE Ventures, Illumina Ventures, Kaiser Permanente Ventures, and HealthInvest Equity Partners. In January, the firm said it closed a funding round worth $11 million and announced the launch of several programs aimed at helping employer groups offer genetics services and physician-guided genetic testing to their employees. At the time, the company said it had raised $23 million to date.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.